Thursday, July 9, 2026

pharma · Microcystic Lymphatic Malformation · Pachyonychia Congenita · PVLA

PALVELLA THERAPEUTICS

PALVELLA THERAPEUTICS drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Wayne, USA HQ
2015 Founded
38 Employees
Public company Type
PVLA · NYSE Ticker
Company details
Status
Public
HQ
Wayne, USA
Founded
2015
Employees
38
Programs
7
Drugs
0
Patents
9
Intelligence · Drug Pipeline

PALVELLA THERAPEUTICS pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

PALVELLA THERAPEUTICS drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →